Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)
NCT02126358 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 290
Last updated 2016-10-18
Summary
To evaluate the efficacy and safety of the fix-dose combination therapy with Gemigliptin 50mg and Rosuvastatin 20mg with type 2 diabetes and dyslipidemia
Conditions
Interventions
- DRUG
-
Gemigliptin and/or Rosuvastatin
Sponsors & Collaborators
-
LG Life Sciences
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2016-03-31
- Completion
- 2016-03-31
Countries
- South Korea
Study Locations
More Related Trials
-
Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
NCT00688558 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Evaluate the Efficacy and Safety of DP-R212
NCT02955368 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins
NCT01859455 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus
NCT01495013 ·Status: COMPLETED ·Phase: PHASE3
-
Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study
NCT01516879 ·Status: COMPLETED ·Phase: PHASE3
-
Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody
NCT02189837 ·Status: COMPLETED ·Phase: PHASE3
-
Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe
NCT02029625 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia
NCT00889226 ·Status: COMPLETED ·Phase: PHASE4
-
LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts
NCT01544309 ·Status: COMPLETED ·Phase: NA
-
To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients
NCT06866509 ·Status: COMPLETED
-
Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension
NCT02842359 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides
NCT00108511 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)
NCT01370590 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia (0653-152)(COMPLETED)
NCT00652847 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
NCT05930028 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia
NCT02714569 ·Status: COMPLETED ·Phase: PHASE1
-
A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia
NCT02944383 ·Status: COMPLETED ·Phase: PHASE2
-
Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED)
NCT00935259 ·Status: COMPLETED ·Phase: PHASE1
-
Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)
NCT02947620 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)
NCT00276458 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Evaluation Of 1.2% Atorvastatin and 1.2% Simvastatin Gel Local Drug Delivery And Redelivery In Chronic Periodontitis Subjects With Diabetes Mellitus: A Randomized Controlled Clinical Trial.
NCT03745300 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
NCT01218204 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy
NCT02571257 ·Status: COMPLETED ·Phase: PHASE2
-
Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)
NCT00409773 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)
NCT00202904 ·Status: COMPLETED ·Phase: PHASE4